Patricia Roukee Sitnitsky, MD
Internal Medicine · Los Altos
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 34
- 10 carriers
- Office
- 1
Offices
1 location · Patricia Sitnitsky PC · 11 clinicians in this group
Hospitals listed: 053174 · 059349 · El Camino Health · Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
34 plans · 10 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Sitnitsky’s office at (408) 495-5770 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
34 of 34 plans
| Aetna Medicare Eagle (PPO) | Aetna Medicare | Listed | Sep 8, 2026 |
| Aetna Medicare Enhanced (PPO) | Aetna Medicare | Listed | Sep 8, 2026 |
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| AARP Medicare Advantage from UHC CA-10 (HMO-POS) | UnitedHealthcare | Listed, may be out of date | Jun 10, 2026 |
California Medical Board record
Licence A88027 · Current
Licensed to practise in California · since 2004 · expires 2027-09-30 · Stanford University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$88,857
Medicare paid this office $88,857 for 210 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 138 | $32,996 | $110 |
| New patient visit (45+ min) | 76 | $8,698 | $114 |
| Short return visit (20+ min) | 54 | $6,539 | $83 |
| Advance care planning, first 30 minutes | 67 | $5,113 | $71 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 28 | $4,414 | $158 |
See all 19 services
| Return visit (30+ min) | 138 | $32,996 | $110 |
| New patient visit (45+ min) | 76 | $8,698 | $114 |
| Short return visit (20+ min) | 54 | $6,539 | $83 |
| Advance care planning, first 30 minutes | 67 | $5,113 | $71 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 28 | $4,414 | $158 |
| Transitional care management services for problem of at least moderate complexity | 13 | $3,046 | $203 |
| Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | 20 | $2,306 | $38 |
| Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | 23 | $2,190 | $49 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 19 | $1,794 | $60 |
| Ultrasound scan of head and neck soft tissue | 19 | $1,690 | $85 |
| Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | 12 | $1,487 | $46 |
| Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | 15 | $1,270 | $53 |
| Assessment of emotional or behavioral problems | 134 | $1,024 | $4 |
| Short return visit | 13 | $613 | $47 |
| Administration of influenza virus vaccine | 15 | $586 | $39 |
| Administration of pneumococcal vaccine | 14 | $547 | $39 |
| Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | 13 | $285 | $22 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 21 | $253 | $12 |
| Injection of drug or substance under skin or into muscle | 14 | $223 | $14 |
Procedures Medicare counted
| Removal of skin lesions | 1-10 | None |
| Removal or shaving of skin growth | 1-10 | None |
Who their Medicare patients are
210 Original Medicare patients in 2024. Average age 76 · Women 65% · Also on Medicaid 35% · Health risk score 1.10. At or below the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 75% · Diabetes 41% · Coronary heart disease 35% · Chronic kidney disease 26% · Depression 26% · Atrial fibrillation 19% · Heart failure 17% · Cancer 13% · Dementia 12% · COPD 10% · Stroke 7%.
The office billed $222,483, Medicare allowed $119,033 and paid $88,857; for 1,260 services of 63 kinds; $5,472 of it was for drugs given in the office and $83,385 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 210 | 1,260 | 76 | 1.10 | $222,483 | $88,857 |
| 2023 | 117 | 490 | 79 | 1.25 | $89,509 | $38,825 |
| 2022 | 21 | 30 | 76 | 1.08 | $16,147 | $2,691 |
| 2016 | 184 | 434 | 75 | 1.02 | $96,484 | $32,370 |
| 2015 | 245 | 713 | 74 | 1.18 | $135,033 | $56,642 |
| 2014 | 209 | 494 | 74 | 1.17 | $100,885 | $35,903 |
| 2013 | 220 | 609 | 75 | 1.13 | $120,819 | $38,296 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 9 services
| Return visit (30+ min) | 75 | $16,241 | $115 |
| New patient visit (45+ min) | 45 | $6,844 | $152 |
| Short return visit (20+ min) | 46 | $5,393 | $73 |
| Advance care planning, first 30 minutes | 35 | $3,296 | $78 |
| New patient visit (30+ min) | 30 | $2,591 | $86 |
| Administration of influenza virus vaccine | 12 | $436 | $36 |
| Injection of drug or substance under skin or into muscle | 16 | $288 | $14 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 18 | $276 | $15 |
| Assessment of emotional or behavioral problems | 19 | $117 | $5 |
2022: 1 service
| Short return visit (20+ min) | 11 | $875 | $80 |
2016: 5 services
| Return visit (30+ min) | 101 | $11,549 | $84 |
| Short return visit (20+ min) | 103 | $7,852 | $56 |
| Pneumococcal vaccine, 13-valent | 24 | $4,150 | $173 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 16 | $2,019 | $126 |
| Administration of pneumococcal vaccine | 32 | $972 | $30 |
2015: 8 services
| Short return visit (20+ min) | 160 | $14,113 | $60 |
| Return visit (30+ min) | 102 | $13,061 | $93 |
| Pneumococcal vaccine, 13-valent | 75 | $11,684 | $152 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 47 | $6,184 | $132 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 14 | $2,656 | $190 |
| Administration of pneumococcal vaccine | 75 | $2,339 | $30 |
| Influenza vaccine split virus, preservative free | 32 | $1,130 | $35 |
| Administration of influenza virus vaccine | 33 | $1,035 | $31 |
2014: 5 services
| Short return visit (20+ min) | 124 | $12,570 | $62 |
| Return visit (30+ min) | 94 | $11,629 | $89 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 30 | $3,763 | $125 |
| Administration of pneumococcal vaccine | 15 | $456 | $30 |
| Administration of influenza virus vaccine | 13 | $395 | $30 |
2013: 4 services
| Short return visit (20+ min) | 157 | $17,290 | $57 |
| Return visit (30+ min) | 101 | $13,845 | $88 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 13 | $1,638 | $126 |
| Inhalation treatment for airway obstruction or sputum production | 11 | $243 | $20 |
Medicaid work
$0 in 2024
Medicaid paid $0 for 169 billed services this clinician did in 2024, up to 23 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| New patient visit (45+ min) | 24 | $0 |
| Return visit (30+ min) | 145 | $0 |
| 2024 | 169 | 2 | 23 | $0 |
| 2023 | 33 | 1 | 18 | $38 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 33 | $38 |
Drugs they prescribed that Part D paid
$382,570
Pharmacies billed $382,570 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
1,784 generic and 418 brand-name prescriptions · $382,570 in drug cost · 75 antibiotic prescriptions to 58 people · 21 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ozempic | 78 | $87,460 | $1,121 |
| Mounjaro | 53 | $56,965 | $1,075 |
| Jardiance | 25 | $24,507 | $980 |
| Prolia | 13 | $20,166 | $1,551 |
| Repatha Sureclick | 18 | $16,383 | $910 |
See all 53 drugs
| Ozempic | 78 | $87,460 | $1,121 |
| Mounjaro | 53 | $56,965 | $1,075 |
| Jardiance | 25 | $24,507 | $980 |
| Prolia | 13 | $20,166 | $1,551 |
| Repatha Sureclick | 18 | $16,383 | $910 |
| Trulicity | 14 | $13,417 | $958 |
| Januvia | 13 | $12,934 | $995 |
| Breo Ellipta | 13 | $6,724 | $517 |
| Abrysvo | 14 | $3,952 | $282 |
| Rosuvastatin | 150 | $1,763 | $12 |
| Ezetimibe | 30 | $1,717 | $57 |
| Levothyroxine | 64 | $797 | $12 |
| Atorvastatin | 101 | $664 | $7 |
| Lisinopril | 82 | $646 | $8 |
| Gabapentin | 37 | $642 | $17 |
| Amlodipine Besylate | 94 | $599 | $6 |
| Fenofibrate | 17 | $551 | $32 |
| Valsartan | 19 | $543 | $29 |
| Metoprolol | 48 | $540 | $11 |
| Metformin | 59 | $536 | $9 |
| Albuterol Sulfate Hfa | 19 | $447 | $24 |
| Isosorbide Dinitrate | 11 | $427 | $39 |
| Mirtazapine | 26 | $372 | $14 |
| Tamsulosin | 23 | $348 | $15 |
| Pantoprazole | 34 | $337 | $10 |
| Omeprazole | 29 | $323 | $11 |
| Quetiapine | 19 | $320 | $17 |
| Hydralazine | 28 | $294 | $11 |
| Escitalopram | 23 | $283 | $12 |
| Losartan | 53 | $254 | $5 |
| Nitrofurantoin Mono-Macro | 16 | $247 | $15 |
| Duloxetine | 19 | $232 | $12 |
| Furosemide | 39 | $226 | $6 |
| Sertraline | 28 | $200 | $7 |
| Metformin Hcl Er | 14 | $188 | $13 |
| Zolpidem | 22 | $183 | $8 |
| Trazodone | 23 | $179 | $8 |
| Donepezil | 21 | $174 | $8 |
| Memantine | 16 | $151 | $9 |
| Fluticasone Propionate | 15 | $126 | $8 |
| Venlafaxine Hcl Er | 12 | $125 | $10 |
| Benazepril | 14 | $117 | $8 |
| Lisinopril-Hydrochlorothiazide | 11 | $116 | $11 |
| Klor-Con 10 | 14 | $112 | $8 |
| Glipizide | 13 | $112 | $9 |
| Allopurinol | 15 | $83 | $6 |
| Triamcinolone Acetonide | 15 | $81 | $5 |
| Citalopram Hbr | 11 | $71 | $6 |
| Simvastatin | 21 | $67 | $3 |
| Azithromycin | 31 | $65 | $2 |
| Hydrochlorothiazide | 21 | $38 | $2 |
| Metoprolol | 19 | $22 | $1 |
| Lorazepam | 16 | $20 | $1 |
Year by year
| 2024 | 2,223 | 313 | None | 19% | $382,570 |
| 2023 | 893 | 208 | 1% (12) | 21% | $143,166 |
| 2022 | 456 | 109 | None | None | $61,308 |
| 2021 | 277 | 69 | 0% (0) | 6% | $18,986 |
| 2019 | 30 | 11 | None | None | $2,301 |
| 2018 | 72 | 22 | None | None | $7,243 |
| 2017 | 569 | 128 | None | None | $42,546 |
| 2016 | 3,090 | 263 | 3% (90) | None | $198,836 |
| 2015 | 2,833 | 284 | 4% (113) | None | $182,633 |
| 2014 | 2,609 | 241 | 5% (129) | None | $175,274 |
| 2013 | 2,751 | 244 | 4% (118) | 26% | $200,431 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 20 drugs
| Ozempic | 26 | $32,182 | $1,238 |
| Rybelsus | 12 | $18,459 | $1,538 |
| Abrysvo | 35 | $11,321 | $323 |
| Shingrix | 27 | $5,452 | $202 |
| Atorvastatin | 50 | $1,098 | $22 |
| Rosuvastatin | 29 | $675 | $23 |
| Metformin | 34 | $624 | $18 |
| Donepezil | 16 | $579 | $36 |
| Gabapentin | 24 | $558 | $23 |
| Levothyroxine | 24 | $540 | $23 |
| Tamsulosin | 15 | $502 | $33 |
| Metoprolol | 14 | $459 | $33 |
| Amlodipine Besylate | 33 | $459 | $14 |
| Escitalopram | 12 | $453 | $38 |
| Lisinopril | 32 | $409 | $13 |
| Losartan | 21 | $335 | $16 |
| Simvastatin | 12 | $290 | $24 |
| Hydralazine | 11 | $235 | $21 |
| Omeprazole | 13 | $143 | $11 |
| Tramadol | 11 | $24 | $2 |
2022: 9 drugs
| Atorvastatin | 35 | $548 | $16 |
| Gabapentin | 17 | $186 | $11 |
| Simvastatin | 19 | $180 | $9 |
| Losartan | 13 | $176 | $14 |
| Amlodipine Besylate | 17 | $172 | $10 |
| Metformin | 31 | $157 | $5 |
| Atenolol | 12 | $153 | $13 |
| Lisinopril | 19 | $130 | $7 |
| Alendronate | 11 | $120 | $11 |
2021: 6 drugs
| Ramipril | 15 | $335 | $22 |
| Atorvastatin | 19 | $232 | $12 |
| Metformin | 19 | $152 | $8 |
| Amlodipine Besylate | 14 | $146 | $10 |
| Lisinopril | 13 | $141 | $11 |
| Simvastatin | 13 | $91 | $7 |
2019: 1 drug
| Latanoprost | 11 | $91 | $8 |
2017: 13 drugs
| Levothyroxine | 39 | $903 | $23 |
| Atorvastatin | 43 | $785 | $18 |
| Nateglinide | 14 | $701 | $50 |
| Gabapentin | 20 | $451 | $23 |
| Metoprolol | 18 | $447 | $25 |
| Losartan | 16 | $437 | $27 |
| Valsartan | 12 | $310 | $26 |
| Metformin | 29 | $190 | $7 |
| Fluticasone Propionate | 12 | $189 | $16 |
| Pantoprazole | 13 | $134 | $10 |
| Lisinopril | 22 | $110 | $5 |
| Simvastatin | 11 | $93 | $8 |
| Amlodipine Besylate | 18 | $77 | $4 |
2016: 73 drugs
| Januvia | 27 | $23,136 | $857 |
| Crestor | 12 | $7,342 | $612 |
| Acitretin | 11 | $7,205 | $655 |
| Xarelto | 13 | $4,607 | $354 |
| Atrovent Hfa | 14 | $4,385 | $313 |
| Invokana | 11 | $4,335 | $394 |
| Atorvastatin | 190 | $3,670 | $19 |
| Dexilant | 15 | $3,648 | $243 |
| Levothyroxine | 138 | $3,509 | $25 |
| Proctozone-Hc | 22 | $3,476 | $158 |
| Metoprolol | 65 | $2,288 | $35 |
| Valsartan | 43 | $1,995 | $46 |
| Fenofibrate | 21 | $1,895 | $90 |
| Gabapentin | 114 | $1,771 | $16 |
| Proair Hfa | 25 | $1,573 | $63 |
| Esomeprazole Magnesium | 14 | $1,256 | $90 |
| Propranolol | 26 | $1,124 | $43 |
| Temazepam | 18 | $1,118 | $62 |
| Duloxetine | 14 | $1,099 | $79 |
| Fluticasone Propionate | 56 | $1,073 | $19 |
| Hydrocodone-Acetaminophen | 32 | $1,035 | $32 |
| Synthroid | 16 | $1,000 | $62 |
| Valsartan-Hydrochlorothiazide | 16 | $992 | $62 |
| Metformin | 101 | $928 | $9 |
| Potassium Chloride | 35 | $914 | $26 |
| Simvastatin | 94 | $895 | $10 |
| Pantoprazole | 41 | $837 | $20 |
| Doxepin | 11 | $771 | $70 |
| Lisinopril | 97 | $767 | $8 |
| Hydrochlorothiazide | 94 | $708 | $8 |
| Losartan | 47 | $642 | $14 |
| Zolpidem | 38 | $617 | $16 |
| Benazepril | 32 | $616 | $19 |
| Omeprazole | 28 | $609 | $22 |
| Ramipril | 20 | $595 | $30 |
| Alendronate | 51 | $578 | $11 |
| Fenofibrate | 13 | $567 | $44 |
| Amlodipine Besylate | 88 | $540 | $6 |
| Atenolol | 52 | $506 | $10 |
| Glipizide | 32 | $480 | $15 |
| Pravastatin | 11 | $473 | $43 |
| Citalopram Hbr | 31 | $418 | $13 |
| Montelukast | 20 | $415 | $21 |
| Oxycodone-Acetaminophen | 18 | $415 | $23 |
| Metoprolol | 53 | $385 | $7 |
| Ketoconazole | 11 | $384 | $35 |
| Allopurinol | 20 | $380 | $19 |
| Hydralazine | 20 | $358 | $18 |
| Clopidogrel | 34 | $352 | $10 |
| Furosemide | 62 | $347 | $6 |
| Ibuprofen | 36 | $305 | $8 |
| Triamterene-Hydrochlorothiazid | 15 | $303 | $20 |
| Ranitidine | 27 | $282 | $10 |
| Escitalopram | 19 | $280 | $15 |
| Trazodone | 33 | $274 | $8 |
| Carvedilol | 32 | $255 | $8 |
| Isosorbide Mononitrate Er | 16 | $254 | $16 |
| Warfarin | 17 | $253 | $15 |
| Nitrofurantoin Mono-Macro | 11 | $235 | $21 |
| Cyclobenzaprine | 19 | $233 | $12 |
| Paroxetine | 16 | $223 | $14 |
| Levetiracetam | 18 | $221 | $12 |
| Triamcinolone Acetonide | 20 | $204 | $10 |
| Lovastatin | 27 | $190 | $7 |
| Azithromycin | 21 | $179 | $9 |
| Sertraline | 14 | $144 | $10 |
| Glimepiride | 12 | $117 | $10 |
| Alprazolam | 14 | $115 | $8 |
| Lisinopril-Hydrochlorothiazide | 14 | $92 | $7 |
| Naproxen | 15 | $78 | $5 |
| Losartan-Hydrochlorothiazide | 11 | $77 | $7 |
| Buspirone | 15 | $73 | $5 |
| Famotidine | 15 | $57 | $4 |
2015: 74 drugs
| Januvia | 23 | $20,014 | $870 |
| Nexium | 27 | $12,845 | $476 |
| Acitretin | 12 | $8,377 | $698 |
| Spiriva | 13 | $5,998 | $461 |
| Advair Diskus | 13 | $5,415 | $417 |
| Zetia | 16 | $5,362 | $335 |
| Atorvastatin | 135 | $3,359 | $25 |
| Atrovent Hfa | 12 | $3,297 | $275 |
| Levothyroxine | 119 | $2,893 | $24 |
| Fentanyl | 20 | $2,157 | $108 |
| Ciprodex | 12 | $2,098 | $175 |
| Fenofibrate | 27 | $2,063 | $76 |
| Metoprolol | 62 | $1,897 | $31 |
| Duloxetine | 11 | $1,864 | $169 |
| Valsartan | 33 | $1,632 | $49 |
| Proair Hfa | 28 | $1,549 | $55 |
| Metronidazole | 11 | $1,490 | $135 |
| Gabapentin | 80 | $1,380 | $17 |
| Hydrocodone-Acetaminophen | 44 | $1,296 | $29 |
| Synthroid | 14 | $1,079 | $77 |
| Propranolol | 22 | $1,032 | $47 |
| Simvastatin | 110 | $1,021 | $9 |
| Hydrochlorothiazide | 123 | $1,010 | $8 |
| Omeprazole | 56 | $964 | $17 |
| Nitrofurantoin | 13 | $944 | $73 |
| Nifedipine Er | 14 | $813 | $58 |
| Voltaren | 16 | $749 | $47 |
| Benazepril | 40 | $738 | $18 |
| Lisinopril | 91 | $723 | $8 |
| Valsartan-Hydrochlorothiazide | 17 | $688 | $40 |
| Ketoconazole | 16 | $650 | $41 |
| Metformin | 66 | $612 | $9 |
| Fenofibrate | 14 | $611 | $44 |
| Oxycodone-Acetaminophen | 13 | $593 | $46 |
| Fluticasone Propionate | 42 | $554 | $13 |
| Losartan | 21 | $531 | $25 |
| Atenolol | 60 | $521 | $9 |
| Glipizide | 32 | $477 | $15 |
| Alendronate | 43 | $474 | $11 |
| Metoprolol | 57 | $450 | $8 |
| Sucralfate | 12 | $362 | $30 |
| Montelukast | 11 | $358 | $33 |
| Zolpidem | 34 | $356 | $10 |
| Clopidogrel | 28 | $321 | $11 |
| Lovastatin | 27 | $287 | $11 |
| Furosemide | 42 | $281 | $7 |
| Warfarin | 18 | $256 | $14 |
| Allopurinol | 15 | $249 | $17 |
| Ramipril | 27 | $249 | $9 |
| Potassium Chloride | 12 | $248 | $21 |
| Pantoprazole | 13 | $235 | $18 |
| Trazodone | 31 | $229 | $7 |
| Triamcinolone Acetonide | 20 | $228 | $11 |
| Citalopram Hbr | 18 | $225 | $12 |
| Nitrofurantoin Mono-Macro | 11 | $215 | $20 |
| Quinapril | 14 | $209 | $15 |
| Amoxicillin-Clavulanate Potass | 12 | $204 | $17 |
| Lorazepam | 22 | $204 | $9 |
| Carvedilol | 16 | $200 | $12 |
| Amlodipine Besylate | 46 | $186 | $4 |
| Azithromycin | 29 | $185 | $6 |
| Klor-Con M10 | 15 | $148 | $10 |
| Paroxetine | 13 | $140 | $11 |
| Lisinopril-Hydrochlorothiazide | 20 | $114 | $6 |
| Cyclobenzaprine | 14 | $113 | $8 |
| Alprazolam | 17 | $109 | $6 |
| Carbidopa-Levodopa | 12 | $107 | $9 |
| Ranitidine | 15 | $104 | $7 |
| Cephalexin | 14 | $103 | $7 |
| Temazepam | 13 | $72 | $6 |
| Ciprofloxacin | 11 | $69 | $6 |
| Risperidone | 11 | $59 | $5 |
| Buspirone | 11 | $47 | $4 |
| Famotidine | 13 | $43 | $3 |
2014: 66 drugs
| Januvia | 19 | $10,578 | $557 |
| Advair Diskus | 24 | $8,797 | $367 |
| Diovan | 29 | $6,222 | $215 |
| Zetia | 24 | $6,010 | $250 |
| Spiriva | 19 | $6,004 | $316 |
| Nexium | 19 | $5,470 | $288 |
| Crestor | 17 | $5,320 | $313 |
| Vesicare | 11 | $3,748 | $341 |
| Atorvastatin | 125 | $3,213 | $26 |
| Metoprolol | 56 | $2,107 | $38 |
| Qvar | 12 | $2,039 | $170 |
| Gabapentin | 64 | $2,038 | $32 |
| Hydrocodone-Acetaminophen | 68 | $1,727 | $25 |
| Valsartan-Hydrochlorothiazide | 22 | $1,628 | $74 |
| Levothyroxine | 97 | $1,599 | $16 |
| Nystatin | 15 | $1,502 | $100 |
| Synthroid | 23 | $1,436 | $62 |
| Fenofibrate | 15 | $1,370 | $91 |
| Omeprazole | 50 | $1,172 | $23 |
| Fluticasone Propionate | 35 | $1,126 | $32 |
| Lisinopril | 90 | $1,033 | $11 |
| Voltaren | 21 | $1,020 | $49 |
| Propranolol | 25 | $998 | $40 |
| Hydralazine | 17 | $967 | $57 |
| Fentanyl | 11 | $962 | $87 |
| Simvastatin | 100 | $954 | $10 |
| Clopidogrel | 37 | $867 | $23 |
| Proair Hfa | 17 | $833 | $49 |
| Hydrochlorothiazide | 101 | $805 | $8 |
| Cyclobenzaprine | 15 | $786 | $52 |
| Rabeprazole | 12 | $784 | $65 |
| Benazepril-Hydrochlorothiazide | 13 | $667 | $51 |
| Sucralfate | 14 | $610 | $44 |
| Fenofibrate | 13 | $603 | $46 |
| Atenolol | 74 | $598 | $8 |
| Benazepril | 37 | $575 | $16 |
| Metformin | 34 | $493 | $15 |
| Donepezil | 18 | $392 | $22 |
| Glipizide | 37 | $391 | $11 |
| Alendronate | 25 | $382 | $15 |
| Losartan | 18 | $350 | $19 |
| Lovastatin | 14 | $336 | $24 |
| Warfarin | 30 | $306 | $10 |
| Carvedilol | 32 | $292 | $9 |
| Ketoconazole | 15 | $253 | $17 |
| Escitalopram | 13 | $249 | $19 |
| Metoprolol | 38 | $244 | $6 |
| Econazole Nitrate | 11 | $232 | $21 |
| Furosemide | 43 | $203 | $5 |
| Carisoprodol | 11 | $200 | $18 |
| Azithromycin | 25 | $196 | $8 |
| Citalopram Hbr | 27 | $192 | $7 |
| Triamterene-Hydrochlorothiazid | 13 | $191 | $15 |
| Zolpidem | 23 | $188 | $8 |
| Trazodone | 35 | $179 | $5 |
| Allopurinol | 19 | $167 | $9 |
| Polyethylene Glycol 3350 | 11 | $166 | $15 |
| Lorazepam | 15 | $155 | $10 |
| Triamcinolone Acetonide | 11 | $150 | $14 |
| Tramadol | 14 | $91 | $7 |
| Alprazolam | 13 | $87 | $7 |
| Temazepam | 15 | $79 | $5 |
| Acetaminophen-Codeine | 11 | $77 | $7 |
| Lisinopril-Hydrochlorothiazide | 19 | $75 | $4 |
| Amlodipine Besylate | 13 | $67 | $5 |
| Pramipexole Dihydrochloride | 11 | $63 | $6 |
2013: 67 drugs
| Januvia | 19 | $12,870 | $677 |
| Diovan | 50 | $9,488 | $190 |
| Advair Diskus | 24 | $8,024 | $334 |
| Zetia | 33 | $7,227 | $219 |
| Spiriva | 16 | $5,567 | $348 |
| Diovan Hct | 21 | $5,416 | $258 |
| Lantus | 20 | $5,356 | $268 |
| Qvar | 28 | $5,251 | $188 |
| Nexium | 13 | $5,087 | $391 |
| Atorvastatin | 117 | $4,919 | $42 |
| Gabapentin | 74 | $3,117 | $42 |
| Fenofibrate | 28 | $3,008 | $107 |
| Lyrica | 12 | $3,005 | $250 |
| Valsartan-Hydrochlorothiazide | 11 | $2,386 | $217 |
| Fluticasone Propionate | 56 | $2,308 | $41 |
| Fenofibrate | 19 | $1,831 | $96 |
| Metoprolol | 42 | $1,830 | $44 |
| Clopidogrel | 36 | $1,830 | $51 |
| Nystop | 19 | $1,389 | $73 |
| Synthroid | 23 | $1,202 | $52 |
| Omeprazole | 61 | $1,193 | $20 |
| Levothyroxine | 86 | $1,103 | $13 |
| Risperidone | 14 | $1,093 | $78 |
| Simvastatin | 90 | $1,073 | $12 |
| Voltaren | 16 | $1,060 | $66 |
| Hydrocodone-Acetaminophen | 67 | $1,012 | $15 |
| Hydralazine | 33 | $982 | $30 |
| Lisinopril | 90 | $874 | $10 |
| Proair Hfa | 18 | $840 | $47 |
| Hydrochlorothiazide | 89 | $774 | $9 |
| Fenofibrate | 13 | $727 | $56 |
| Benazepril | 36 | $664 | $18 |
| Losartan | 21 | $626 | $30 |
| Carisoprodol | 11 | $574 | $52 |
| Amlodipine Besylate | 39 | $571 | $15 |
| Metformin | 31 | $566 | $18 |
| Atenolol | 72 | $510 | $7 |
| Carvedilol | 37 | $478 | $13 |
| Metoprolol | 38 | $474 | $12 |
| Lovastatin | 21 | $452 | $22 |
| Alendronate | 30 | $414 | $14 |
| Fosinopril | 16 | $378 | $24 |
| Amox Tr-Potassium Clavulanate | 14 | $360 | $26 |
| Sertraline | 22 | $349 | $16 |
| Glipizide | 20 | $344 | $17 |
| Warfarin | 30 | $341 | $11 |
| Venlafaxine Hcl Er | 17 | $339 | $20 |
| Pravastatin | 11 | $305 | $28 |
| Azithromycin | 33 | $292 | $9 |
| Furosemide | 49 | $292 | $6 |
| Cyclobenzaprine | 13 | $266 | $20 |
| Zolpidem | 36 | $255 | $7 |
| Econazole Nitrate | 11 | $255 | $23 |
| Triamterene-Hctz | 11 | $237 | $22 |
| Medroxyprogesterone Acetate | 15 | $217 | $14 |
| Lorazepam | 26 | $194 | $7 |
| Citalopram Hbr | 19 | $187 | $10 |
| Nitrostat | 16 | $181 | $11 |
| Acetaminophen-Codeine | 11 | $171 | $16 |
| Lisinopril-Hydrochlorothiazide | 14 | $160 | $11 |
| Methadone | 16 | $146 | $9 |
| Trazodone | 18 | $145 | $8 |
| Phenytoin Sodium Extended | 12 | $143 | $12 |
| Alprazolam | 15 | $101 | $7 |
| Temazepam | 13 | $75 | $6 |
| Propranolol | 14 | $71 | $5 |
| Dipyridamole | 11 | $69 | $6 |
Money from drug and device companies
$2,243 in 2025
| 2025 | 19 | 77 | None | $2,243 |
| 2024 | 13 | 82 | $1,050 | $3,214 |
| 2023 | 7 | 26 | None | $583 |
| 2022 | 4 | 10 | None | $558 |
| 2020 | 5 | 6 | None | $160 |
| 2019 | 7 | 14 | None | $348 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Lundbeck | Vyepti | $271 | 8 payments
|
| Abbvie | Qulipta | $251 | 7 payments
|
| Pfizer | Eliquis | $248 | 14 payments
|
| Gilead Sciences | Yeztugo | $241 | 6 payments
|
| Lilly USA | Kisunla | $238 | 8 payments
|
| ViiV Healthcare | Apretude | $199 | 6 payments
|
See all 77 published payments
| Pfizer | Meals · 2025-12-16 | Eliquis | $24 |
| Gilead Sciences | Meals · 2025-12-15 | None | $31 |
| Currax Pharmaceuticals | Meals · 2025-12-11 | Contrave | $17 |
| Abbvie | Meals · 2025-12-04 | Qulipta | $6 |
| Astellas Pharma US | Meals · 2025-12-02 | Veozah | $24 |
| Pfizer | Meals · 2025-11-17 | Eliquis | $6 |
| Salix Pharmaceuticals a division of Bausch Health US | Meals · 2025-11-05 | Xifaxan | $20 |
| Amgen | Meals · 2025-11-04 | Otezla | $31 |
| Pfizer | Meals · 2025-10-31 | Nurtec Odt | $29 |
| Pfizer | Meals · 2025-10-27 | Nurtec Odt | $23 |
| ViiV Healthcare | Meals · 2025-10-22 | Apretude | $17 |
| Abbvie | Meals · 2025-10-15 | Ubrelvy | $29 |
| Eisai | Meals · 2025-10-14 | Leqembi | $125 |
| Lilly USA | Meals · 2025-10-09 | Kisunla | $119 |
| Phadia US | Meals · 2025-10-07 | Immunocap | $17 |
| Invivyd | Meals · 2025-10-01 | Pemgarda | $33 |
| Lilly USA | Meals · 2025-09-17 | Mounjaro | $23 |
| Lilly USA | Meals · 2025-09-15 | Kisunla | $22 |
| Lilly USA | Meals · 2025-09-15 | Kisunla | $5 |
| Novo Nordisk | Meals · 2025-09-10 | Wegovy | $0 |
| Novo Nordisk | Meals · 2025-09-10 | Wegovy | $6 |
| Abbvie | Meals · 2025-09-10 | Botox | $20 |
| Pfizer | Meals · 2025-08-27 | Nurtec Odt | $17 |
| Pfizer | Meals · 2025-08-18 | Eliquis | $25 |
| Eisai | Meals · 2025-08-18 | Leqembi | $26 |
| Gilead Sciences | Meals · 2025-08-14 | Yeztugo | $122 |
| Gilead Sciences | Meals · 2025-08-14 | None | $21 |
| Novo Nordisk | Meals · 2025-08-13 | None | $22 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-08-11 | Trintellix | $20 |
| Novo Nordisk | Meals · 2025-08-06 | Wegovy | $25 |
| ViiV Healthcare | Meals · 2025-08-06 | Apretude | $14 |
| ViiV Healthcare | Meals · 2025-08-06 | Apretude | $5 |
| Baxter Healthcare | Meals · 2025-08-01 | Hillrom - Carnation Ambulatory Monitor | $30 |
| Abbvie | Meals · 2025-07-24 | Botox | $30 |
| Lundbeck | Meals · 2025-07-17 | Vyepti | $30 |
| Gilead Sciences | Meals · 2025-07-10 | None | $30 |
| Salix Pharmaceuticals a division of Bausch Health US | Meals · 2025-07-01 | Xifaxan | $23 |
| Pfizer | Meals · 2025-06-25 | Eliquis | $25 |
| Novo Nordisk | Meals · 2025-06-24 | Wegovy | $28 |
| Gilead Sciences | Meals · 2025-06-23 | None | $21 |
| Lundbeck | Meals · 2025-06-19 | Vyepti | $8 |
| Lundbeck | Meals · 2025-06-18 | Vyepti | $0 |
| Gilead Sciences | Meals · 2025-05-28 | None | $17 |
| Novo Nordisk | Meals · 2025-05-20 | Rybelsus | $24 |
| Pfizer | Meals · 2025-05-19 | Eliquis | $15 |
| Lundbeck | Meals · 2025-05-16 | Rexulti | $28 |
| ViiV Healthcare | Meals · 2025-05-14 | Apretude | $122 |
| Lilly USA | Meals · 2025-05-13 | Kisunla | $16 |
| Salix Pharmaceuticals a division of Bausch Health US | Meals · 2025-05-12 | Xifaxan | $19 |
| Novo Nordisk | Meals · 2025-05-08 | Ozempic | $21 |
| Lundbeck | Meals · 2025-05-07 | Vyepti | $25 |
| Lilly USA | Meals · 2025-04-29 | Mounjaro | $17 |
| Novo Nordisk | Meals · 2025-04-29 | Ozempic | $26 |
| Pfizer | Meals · 2025-04-22 | Eliquis | $22 |
| ViiV Healthcare | Meals · 2025-04-16 | Apretude | $17 |
| Pfizer | Meals · 2025-04-10 | Eliquis | $7 |
| Exact Sciences | Meals · 2025-04-09 | The Cologuard Plus Collection Kit | $21 |
| Lilly USA | Meals · 2025-03-25 | Mounjaro | $21 |
| Merck Sharp & Dohme | Meals · 2025-03-18 | Varivax | $19 |
| Pfizer | Meals · 2025-03-17 | Eliquis | $21 |
| Abbvie | Meals · 2025-03-12 | Qulipta | $125 |
| Lundbeck | Meals · 2025-03-11 | Vyepti | $25 |
| Novo Nordisk | Meals · 2025-03-07 | Ozempic | $16 |
| Otsuka America Pharmaceutical | Meals · 2025-03-05 | Rexulti | $124 |
| Exact Sciences | Meals · 2025-03-05 | Cologuard Collection Kit | $21 |
| Currax Pharmaceuticals | Meals · 2025-03-03 | Contrave | $18 |
| Lilly USA | Meals · 2025-02-11 | Zepbound | $15 |
| Exact Sciences | Meals · 2025-01-30 | Cologuard Collection Kit | $20 |
| Abbvie | Meals · 2025-01-29 | Ubrelvy | $24 |
| Pfizer | Meals · 2025-01-28 | Eliquis | $7 |
| Amgen | Meals · 2025-01-23 | Tavneos | $17 |
| ViiV Healthcare | Meals · 2025-01-16 | Apretude | $24 |
| Lundbeck | Meals · 2025-01-16 | Vyepti | $29 |
| Lundbeck | Meals · 2025-01-16 | Vyepti | $125 |
| Pfizer | Meals · 2025-01-15 | Eliquis | $6 |
| Abbvie | Meals · 2025-01-07 | Qulipta | $16 |
| Pfizer | Meals · 2025-01-03 | Eliquis | $19 |
See earlier years (2024, 2023, 2022, 2020, 2019)
2024: $3,214
| GlaxoSmithKline | None | $1,050 | 4 payments
|
| Abbvie | Qulipta | $514 | 18 payments
|
| ViiV Healthcare | Apretude | $283 | 14 payments
|
| Novo Nordisk | Ozempic | $277 | 11 payments
|
| Lilly USA | Mounjaro | $272 | 7 payments
|
| Kyowa Kirin | Nourianz | $173 | 3 payments
|
| Amgen | Repatha | $160 | 4 payments
|
| Pfizer | Nurtec Odt | $146 | 10 payments
|
| Gilead Sciences | None | $139 | 7 payments
|
| Lundbeck | Vyepti | $125 | 1 payment
|
| Regeneron Healthcare Solutions | Dupixent | $26 | 1 payment
|
| iRhythm Technologies | Zio Monitor | $26 | 1 payment
|
| Novartis Pharmaceuticals | None | $23 | 1 payment
|
2023: $583
| ViiV Healthcare | Apretude | $260 | 9 payments
|
| AbbVie | Botox | $129 | 7 payments
|
| Lilly USA | Mounjaro | $78 | 4 payments
|
| Novo Nordisk | Wegovy | $49 | 2 payments
|
| Inspire Medical Systems | Inspire | $29 | 2 payments
|
| Idorsia Pharmaceuticals US | Quviviq | $19 | 1 payment
|
| Merck Sharp & Dohme | Belsomra | $19 | 1 payment
|
2022: $558
| Abbvie | Ubrelvy | $273 | 3 payments
|
| Novo Nordisk | Wegovy | $148 | 5 payments
|
| Lilly USA | Mounjaro | $125 | 1 payment
|
| ViiV Healthcare | Apretude | $12 | 1 payment
|
2020: $160
| Gilead Sciences | None | $57 | 2 payments
|
| Topcon Healthcare Solutions | Harmony | $36 | 1 payment
|
| Radius Health | Tymlos | $30 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $20 | 1 payment
|
| Alfasigma USA | None | $17 | 1 payment
|
2019: $348
| Novo Nordisk | Saxenda | $182 | 7 payments
|
| Stryker | Bacs | $48 | 1 payment
|
| Amgen | Aimovig | $31 | 1 payment
|
| Sanofi Pasteur | Fluzone High-Dose | $28 | 2 payments
|
| Zyla Life Sciences | Sprix | $21 | 1 payment
|
| Novartis Pharmaceuticals | Aimovig | $20 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Bevespi Aerosphere | $17 | 1 payment
|
Professional record
- NPI
- 1790896231
- Licence
- CA A88027California A88027: Current · expires 2027-09-30
- Trained
- Stanford University School of Medicine, 2002
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Internal medicine (207R00000X); Federal specialty code 207RB0002X (207RB0002X)
- Mailing address
- 827 Altos Oaks Dr Ste 4, Los Altos, CA, 94024
- NPI first listed
- 2006-08-31
- NPI last updated
- 2025-05-29
- NPI record certified
- 2025-05-29
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 525 South Dr Ste 211, Mountain View, CA, 94040